Clinical Proteomics Centers for Infectious Diseases and Biodefense

About

What services does this resource provide?

The Clinical Proteomics Centers for Infectious Diseases and Biodefense apply state-of-the-art proteomics technologies for the discovery, qualification, and verification of protein biomarkers in well-defined clinical samples collected for infectious diseases caused by NIAID Category A-C biodefense pathogens and emerging and re-emerging infectious diseases. At the conclusion of the verification phase of each project conducted by the Clinical Proteomics Centers (CPCs), scientists from the CPCs and their collaborators will be allowed three months to prepare and submit a manuscript for publication prior to putting the associated data in the public domain via the CPC websites and other public databases as appropriate. Candidate biomarkers will then be made available to the scientific community on the centers' websites, where they will be freely available to the public.

Where are services provided?

Proteomic analyses on well-defined case versus control clinical samples will be performed by

• University of Texas Medical Branch at Galveston
• Caprion Proteomics, Inc.

Access

The Clinical Proteomics Centers for Infectious Diseases and Biodefense are no longer accepting requests for collaborative research projects to identify candidate pathogen and/or host protein biomarkers.

Highlights

• Supporting the Research Community Through New TB Resource at PATRIC Bioinformatics Resource Center - May 2013
• NIAID Influenza Genome Sequencing Project sequences more than 10,000 influenza genomes—January 2013
• Funding Opportunity: Genomic Centers for Infectious Diseases (U19)
• Funding Opportunity: Evaluation of Multi-‘omic Data in Understanding the Human Microbiome’s Role in Health and Disease (U54)
• Building on a Decade of Accomplishments: Report of the 2010 Blue Ribbon Panel on Genomics (PDF)

Related Resources and Information

• Related NIAID-Supported Services